Hurricane Sandy blows back drug apps at the FDA

Some regulatory teams in the biopharma industry may be left on tenterhooks as they go into overtime waiting for official word on their drug applications. Hurricane Sandy put a crimp in the FDA's schedule. The agency--closed on the 29th and 30th of October--says it may have to tap the brakes on some drug and device applications, with a two-day delay on some drug and device decisions due after October 31. Story